Stay updated on Nivolumab Combo for Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo for Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Combo for Uveal Melanoma Clinical Trial page
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check86 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a Phase 2 study on uveal melanoma and the addition of new collaborators and a revision number. The core content regarding the study's methodology and findings has been largely deleted.SummaryDifference42%
Stay in the know with updates to Nivolumab Combo for Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo for Uveal Melanoma Clinical Trial page.